NBI-56418

· Abbott

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-56418, covering 2012-02-22 to 2012-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Endometriosis Trial: Study of NBI-56418 in Endometriosis [Phase 2]